Pappas Ventures

Pappas Ventures provides investment in the life sciences sector.

Business Model:

Revenue: $4.8M

Employees: 2-10

Rankings

Detailed Pappas Ventures Information

Geographic Data

Pappas Ventures headquarters map

Address: 2520 Meridian Pkwy

City: Durham

State: NC

Zip: 27713

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Pappas Ventures specializing in seed, start-ups, early, mid and growth capital investments. 

Contact Phone:
+19199983300

Contact Email:

Announced Date Company Transaction Money Raised
6/2015 Milestone Pharmaceuticals Series B 0
5/2011 CardioDx Private Equity Round 60M
8/2006 LipoScience Series F 13M
8/2009 Biosyntech Venture Round 1.4M
8/2010 CeNeRx BioPharma Series C 0
9/2006 Anthera Pharmaceuticals Venture Round 0
11/2013 Envisia Therapeutics Series A 25M
5/2005 Bayhill Therapeutics Series B 35.4M
5/2013 Lumena Pharmaceuticals Series A 23M
6/2011 TESARO Series B 101M
8/2016 Rotation Medical Series B 12M
7/2014 Rotation Medical Series B 27.2M
8/2008 Anthera Pharmaceuticals Venture Round 0
2/2012 CeNeRx BioPharma Series D 4.6M
3/2014 Lumena Pharmaceuticals Series B 45M
5/2004 NuVasive Venture Round 9.8M
5/2010 CardioDx Series D 34.5M
4/2007 Syndax Pharmaceuticals Series A 40M
9/2012 IlluminOss Medical Series C 0
4/2013 Afferent Pharmaceuticals Series B 5M
3/2015 Thrasos Series D 21M
10/2012 Thrasos Series C 35M
6/2011 Ultragenyx Pharmaceutical Series A 45M
8/2009 Barosense Series D 27M
6/2007 Cequent Pharmaceuticals Series A 9M
10/2018 VelosBio Series A 58M
3/2010 Syndax Pharmaceuticals Series A 9M
4/2006 Bayhill Therapeutics Venture Round 15.8M
1/2010 Liquidia Technologies Series C 20M
7/2012 CardioDx Private Equity Round 0
7/2017 Kezar Life Sciences Series B 0
7/2007 TargeGen Series D 40M
10/2016 Evidation Health Series B 0
3/2008 BrainCells Series B 30M
12/2012 Ultragenyx Pharmaceutical Series B 75M
6/2011 Milestone Pharmaceuticals Series A 0
10/2007 Optherion Series A 37M
12/2010 TYRX Venture Round 20M
8/2007 FlowCardia Series C 0
3/2015 Balance Therapeutics Series A 18M
6/2007 Gentis Series A 10M
8/2010 Achillion Pharmaceuticals Post-IPO Equity 50.1M
3/2015 Aura Biosciences Series B 0
7/2010 Liquidia Technologies Series C 5M
2/2011 Chimerix Series F 45M
11/2007 LEAD Therapeutics Series A 17M
12/2009 Afferent Pharmaceuticals Series A 23M
1/2006 CoLucid Pharmaceuticals Series A 0
1/2015 CoLucid Pharmaceuticals Series C 0
8/2011 CoLucid Pharmaceuticals Venture Round 0
7/2008 CoLucid Pharmaceuticals Series B 0
10/2018 VelosBio Series A 0
7/2017 Kezar Life Sciences Series B 0
10/2016 Evidation Health Series B 0
8/2016 Rotation Medical Series B 0
6/2015 Milestone Pharmaceuticals Series B 0
3/2015 Thrasos Series D 0
3/2015 Balance Therapeutics Series A 0
3/2015 Aura Biosciences Series B 0
1/2015 CoLucid Pharmaceuticals Series C 0
7/2014 Rotation Medical Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research